CN Patent

CN106714800A — 用于治疗hiv的toll样受体调节剂

Assigned to Gilead Sciences Inc · Expires 2017-05-24 · 9y expired

What this patent protects

提供了用于治疗HIV感染的包含TLR7调节剂的方法、用途、药物方案、药物组合物和试剂盒，所述TLR7调节剂包括式II的那些以及其药学可接受的盐。

USPTO Abstract

提供了用于治疗HIV感染的包含TLR7调节剂的方法、用途、药物方案、药物组合物和试剂盒，所述TLR7调节剂包括式II的那些以及其药学可接受的盐。

Drugs covered by this patent

Patent Metadata

Patent number
CN106714800A
Jurisdiction
CN
Classification
—
Expires
2017-05-24
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.